Ignite Creation Date:
2025-12-26 @ 11:13 AM
Ignite Modification Date:
2026-01-01 @ 5:26 AM
Study NCT ID:
NCT01055028
Status:
TERMINATED
Last Update Posted:
2018-03-26
First Post:
2010-01-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma
Sponsor:
Stanford University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-02
Start Date Type:
None
Primary Completion Date:
2016-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-06-24
Completion Date Type:
ACTUAL
First Submit Date:
2010-01-21
First Submit QC Date:
None
Study First Post Date:
2010-01-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-12-19
Results First Submit QC Date:
None
Results First Post Date:
2018-03-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-02-23
Last Update Post Date:
2018-03-26
Last Update Post Date Type:
ACTUAL